Stomach cancer, though not as common as some other forms of cancer, can be a serious and life-threatening condition if not ...

AstraZeneca's experimental antibody-drug conjugate sonesitatug vedotin has doubled overall survival in a late-stage trial for ...

Two Phase 3 trials presented at Europe's leading oncology conference show major survival gains: Roche's divarasib outperforms ...

AstraZeneca's groundbreaking cancer drug significantly boosts stomach cancer survival rates, offering hope to patients.

Gastrointestinal diseases are those that affect any section of the gastrointestinal tract, from the oesophagus to the rectum, and the accessory digestive organs – liver, gall bladder and pancreas. The ...

Scientists have discovered that a potential new drug can reverse severe fatty liver disease in animal models by restoring gut ...

First Tracks Biotherapeutics reported what it called positive top-line results from an early-stage trial of its treatment for celiac disease. The company said Monday its treatment, ANB033, achieved a ...

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Gastrointestinal Drugs Market - A Global and Regional Analysis: Focus on Application, Route of Administration, Distribution Channel, Drug Class, and ...